Nurse prepares a dose of the COVID-19 vaccine during home visits near Wirksworth, Derbyshire Britain. File/Reuters
Britain’s medical regulator on Thursday said it would fast-track vaccines for coronavirus variants, adding that the makers of already-authorised shots would not need new lengthy clinical trials to prove their adapted vaccines will work.
There is concern that some variants, such as those first found in South Africa and Brazil, may reduce the efficacy of the first generation of COVID-19 vaccines, and manufacturers are looking to adapt their shots.
The accelerated process is based on that used for seasonal flu vaccines each year, the Medicines & Healthcare products Regulatory Agency (MHRA) said, and would be based on robust evidence that the shots create an immune response, rather than full clinical trials.
“Our priority is to get effective vaccines to the public in as short a time as possible, without compromising on safety,” said Christian Schneider, chief scientific officer at the MHRA.
“Should any modifications to authorised COVID-19 vaccines be necessary, this regulatory approach should help to do just that.”
The MHRA said that researchers would be able to measure protection by looking at antibodies in the blood after vaccination.
As well as data on immune response, vaccine makers will need evidence the vaccine is safe, and data from original clinical trials and real-world evidence from vaccine rollout could also be used.
The MHRA said it had developed the advice in conjunction with regulators in Australia, Canada, Singapore and Switzerland.
AstraZeneca, Pfizer and Moderna, the makers of the three vaccines the MHRA has approved for use so far, have all said they are aiming to modify their shots to cope with variants this year.
Britain, which is rolling out shots made by AstraZeneca and Pfizer, has given a first shot of a vaccine to over 20 million people. Despite regulatory approval, Moderna’s vaccine is yet to be rolled out in the country.
Each casualty of the virus lost an average of 10 years of life when they died, according to an analysis by respected think tank the Health Foundation.
New cases totalled 6,040, a slight rise on Friday's 5,947, government data showed, while the number of people who had received the first dose of a COVID-19 vaccine rose to 21,796,278.
The latest EU-UK row is about an AstraZeneca plant in the Netherlands, which Prime Minister Boris Johnson's government claims as part of the British vaccine supply chain.
Furthering its commitment to promoting books and literacy, Sharjah Book Authority (SBA) is organising the National Libraries Summit on November 8 – 9, 2021 at its headquarters in Sharjah. The two-day summit will be held in conjunction with the 40th Sharjah International Book Fair (SIBF 2021) under the theme ‘Visibility, Engagement, Impact, and Collaboration’, and convene 50 national library directors and senior staff from 20 countries in Europe, North America, Africa and the MENA region.
Federal Minister for Information and Broadcasting Chaudhry Fawad Hussain has said that their government is making special arrangements for Sikhs around the world to attend the upcoming celebrations of the birth anniversary of Guru Nanak which will be held in Kartarpur, Punjab, Pakistan.
The envoys issued a highly unusual joint statement on Monday saying the continued detention of Parisian-born philanthropist and activist Osman Kavala "cast a shadow" over Turkey.